LONDON REGENERATIVE MEDICINE NETWORK
44 ORANGE ROW, BRIGHTON  BN1 1UQ- Active - Proposal to Strike off
- PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
- Company No. 06507696
- Last Updated: 01 Mar 2022
Company Profile
LONDON REGENERATIVE MEDICINE NETWORK was incorporated on Monday, February 18, 2008 as a PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) with registered address in BRIGHTON. LONDON REGENERATIVE MEDICINE NETWORK has the status: Active - Proposal to Strike off and it's listed in the following category: Research and experimental development on biotechnology. This PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) has been operating for 17 years and 5 days.
Name | LONDON REGENERATIVE MEDICINE NETWORK |
---|---|
Company number | 06507696 |
Company type | PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) |
Incorporation date | 18 Feb 2008 |
Status | Active - Proposal to Strike off |
Industry (SIC 2007) |
Address
Registered Address |
44 ORANGE ROW BRIGHTON BN1 1UQ |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Christopher Mason Nationality: British |
Dates: Saturday, February 18, 2017 - present
significant influence or control
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 30 December |
Next annual accounts due | 27 December 2021, (-1154 days left) |
Latest accounts | 31 December 2019 |
Next confirmation statement due | 18 March 2017 |
Last confirmation statement dated | 18 February 2016 |
Mortgages
No mortgages have been registered against LONDON REGENERATIVE MEDICINE NETWORK.
Previous Names
Name | Change Date |
---|---|
LONDON REGENERATIVE MEDICINE NETWORK | 18 Feb 2008 |